Ep. 126: Sex and gender differences in Alzheimer’s disease
Moderator: Luca Cuffaro (Milano, Italy) Guest: Julie Novakova Martinkova (Prague, Czechia) In this episode, Dr. Luca Cuffaro and Dr. Julie Novakova Martinkova discuss sex and gender differences in A...
15 Joulu 202424min
Ep. 125: Navigating Gender Differences in Neurology Careers
Moderator: Alice Accorroni (Geneva, Switzerland) Guest: Marianne de Visser (Amsterdam, Netherlands) In this week’s episode Alice Accorroni and Marianne de Visser discuss the multifaceted impact of ge...
8 Joulu 202424min
Ep. 124: Insights into the EAN Leadership Programme
Ean Moderator: Anja Sander (Vienna, Austria) Guest: Peter Dedeken (Sint-Katelijne-Waver, Belgium) Guest: Vanessa Carvalho (Lisbon, Portugal) This week we are happy to share an episode about the EAN L...
1 Joulu 202425min
Ep. 123: News on the risk of malformations and developmental impairment among the offspring of male patients under antiseizure medication
Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany) Guest: Jakob Christensen (Aarhus, Denmark) In this last November episode Bernhard Steinhoff and Jakob Christensen give an update on new data con...
24 Marras 202416min
Ep. 122: News on the risk of malformations and developmental impairment among the offspring of female patients under antiseizure medication
Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany) Guest: Jakob Christensen (Aarhus, Denmark) This week Bernhard Steinhoff talks with Jakob Christensen about the latest news on the risk of antisei...
17 Marras 202418min
Ep. 121: New developments concerning neurostimulation in epilepsy
Moderator: Bernhard J. Steinhoff (Kehl-Kork, Germany) Guest: Kristl Vonck (Gent, Belgium) In this episode, Bernhard Steinhoff speaks with expert Kristl Vonck on the latest advancements in neurostimula...
10 Marras 202421min
Ep. 119: Phase 2 HOPE clinical trial results
Moderator: Theodoros M. Mavridis (Dublin, Ireland) Guest: Messoud Ashina (Glostrup, Denmark) In this episode Theodoros M. Mavridis and Messoud Ashina delve into the findings of the Phase 2 HOPE clini...
27 Loka 202423min
